Migraide Tablet
NDC Package 68466-3391-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Migraide (cyclamen purpurascens tuber, black cohosh, iris versicolor whole, gelsemium sempervirens whole, sanguinaria canadensis root) tablets is for the temporary relief of minor aches & pains associated with headaches or migraine headaches. This formulation utilizes a tablet delivery system. Marketed by Schwabe Mexico, S.a. De C.v., this product is identified by NDC 68466-3391.

Identification & Billing

NDC Package Code
68466-3391-4
Package Description
4 BLISTER PACK in 1 BOX / 10 TABLET in 1 BLISTER PACK
Product Code
68466-3391
11-Digit Billing Format
68466339104

Clinical Specifications

Proprietary Name
Migraide
Non-Proprietary Name
Cyclamen Purpurascens Tuber, Black Cohosh, Iris Versicolor Whole, Gelsemium Sempervirens Whole, Sanguinaria Canadensis Root
Substance Name
Black Cohosh; Cyclamen Purpurascens Tuber; Gelsemium Sempervirens Whole; Iris Versicolor Whole; Sanguinaria Canadensis Root
Dosage Form
Tablet - A solid dosage form containing medicinal substances with or without suitable diluents.
Administration Route
  • Sublingual - Administration beneath the tongue.
  • Sublingual - Administration beneath the tongue.
Active Ingredient(s)
Usage Information
For the temporary relief of minor aches & pains associated with headaches or migraine headaches.

Regulatory & Marketing

Labeler Name
Schwabe Mexico, S.a. De C.v.
Product Type
Human Otc Drug
Marketing Category
UNAPPROVED HOMEOPATHIC - A category specifying that a product is marketed as unapproved homeopathic product.
Start Marketing Date
11-09-2021
End Marketing Date
01-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 68466-3391-4 identifies a specific commercial package of 4 blister pack in 1 box / 10 tablet in 1 blister pack of Migraide, a human over the counter drug labeled by Schwabe Mexico, S.a. De C.v.. This tablet is formulated for sublingual; sublingual use and contains black cohosh; cyclamen purpurascens tuber; gelsemium sempervirens whole; iris versicolor whole; sanguinaria canadensis root as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Schwabe Mexico, S.a. De C.v. on November 09, 2021.

How is this Schwabe Mexico, S.a. De C.v. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 68466339104. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
68466-3391-4
11-Digit CMS (5-4-2)
68466-3391-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.